Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of SARP-1 for the treatment and/or prevention of scleroderma

Use of SARP-1 for the treatment and/or prevention of scleroderma

US Patent 7341995 · Granted Mar 11, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies specific for MMP92019
Monoclonal antibody directed against CXCR52017
Method of treatment by the administration of inhibitors of GM-CSF and IL-172016
Treatment of fibrotic disease2012
vWFA and/or ANT—IG domain containing proteins2012
Cell surface glycoprotein2012
Method of treatment comprising administration of a cytokine antagonist molecule2010
Soluble CD164 polypeptides2010
Isolated INSP 163 protein2010
Methods for treating interleukin-18 mediated disorders with interleukin-18 bindi2010
CXC-chemokine antagonists isolated from Rhipicephalus sanguineus2010
Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES2010